The Cooper Cos., Inc. (COO)
75.81
-0.41
(-0.54%)
USD |
NASDAQ |
Aug 24, 16:00
75.92
+0.11
(+0.15%)
After-Hours: 20:00
Cooper Cos. Enterprise Value : 17.18B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 17.18B |
| August 20, 2026 | 17.16B |
| August 19, 2026 | 17.28B |
| August 18, 2026 | 17.09B |
| August 17, 2026 | 16.96B |
| August 14, 2026 | 17.17B |
| August 13, 2026 | 17.25B |
| August 12, 2026 | 17.28B |
| August 11, 2026 | 17.29B |
| August 10, 2026 | 17.20B |
| August 07, 2026 | 16.79B |
| August 06, 2026 | 16.61B |
| August 05, 2026 | 16.91B |
| August 04, 2026 | 16.88B |
| August 03, 2026 | 16.79B |
| July 31, 2026 | 16.42B |
| July 30, 2026 | 16.48B |
| July 29, 2026 | 16.56B |
| July 28, 2026 | 16.37B |
| July 27, 2026 | 16.02B |
| July 24, 2026 | 16.02B |
| July 23, 2026 | 16.01B |
| July 22, 2026 | 16.06B |
| July 21, 2026 | 16.16B |
| July 20, 2026 | 16.27B |
| Date | Value |
|---|---|
| July 17, 2026 | 16.30B |
| July 16, 2026 | 16.57B |
| July 15, 2026 | 16.08B |
| July 14, 2026 | 15.67B |
| July 13, 2026 | 16.22B |
| July 10, 2026 | 16.10B |
| July 09, 2026 | 16.16B |
| July 08, 2026 | 15.89B |
| July 07, 2026 | 16.33B |
| July 06, 2026 | 16.47B |
| July 02, 2026 | 16.78B |
| July 01, 2026 | 16.34B |
| June 30, 2026 | 16.30B |
| June 29, 2026 | 16.24B |
| June 26, 2026 | 16.16B |
| June 25, 2026 | 16.09B |
| June 24, 2026 | 15.74B |
| June 23, 2026 | 15.21B |
| June 22, 2026 | 15.07B |
| June 18, 2026 | 15.17B |
| June 17, 2026 | 15.00B |
| June 16, 2026 | 15.45B |
| June 15, 2026 | 15.53B |
| June 12, 2026 | 15.55B |
| June 11, 2026 | 15.48B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 11.18B |
| West Pharmaceutical Services, Inc. | 24.74B |
| Abbott Laboratories | 229.49B |
| Stryker Corp. | 138.34B |
| Solventum Corp. | 20.12B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -77.90M |
| Revenue (Quarterly) | 1.082B |
| Total Expenses (Quarterly) | 1.159B |
| EPS Diluted (Quarterly) | -0.3995 |
| Gross Profit Margin (Quarterly) | 63.59% |
| Profit Margin (Quarterly) | -7.20% |
| Earnings Yield | 1.56% |
| Operating Earnings Yield | 5.14% |
| Normalized Earnings Yield | 2.848 |